相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Hussein A. Tawbi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
Alessio Cortellini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab
James L. Alexander et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials
M. Chalabi et al.
ANNALS OF ONCOLOGY (2020)
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Nicholas A. Kennedy et al.
GUT (2020)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer et al.
LANCET (2020)
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis
Nick Powell et al.
Lancet Gastroenterology & Hepatology (2020)
Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitis
Hajir Ibraheim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Can Immune Checkpoint Inhibitors Induce Microscopic Colitis or a Brand New Entity?
Kati Choi et al.
INFLAMMATORY BOWEL DISEASES (2019)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher Andrew Lamb et al.
GUT (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
Michael S. Hughes et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Topical beclometasone dipropionate in the management of immune checkpoint inhibitor-induced microscopic colitis
Hajir Ibraheim et al.
BMJ CASE REPORTS (2019)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 28, pg 119, 2017)
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2018)
High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma
Alexander T. Faje et al.
CANCER (2018)
Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis
Yinghong Wang et al.
INFLAMMATORY BOWEL DISEASES (2018)
Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management
Mark A. Samaan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
Yinghong Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
Kathryn C. Arbour et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management
Marnix H. Geukes Foppen et al.
ESMO OPEN (2018)
MICROSCOPIC COLONIC INFLAMMATION IN IMMUNE CHECK POINT INHIBITOR-INDUCED DIARRHOEA/COLITIS
Hajir Ibraheim et al.
GUT (2018)
Patterns of steroid use in diarrhoea and/or colitis (D/C) from immune checkpoint inhibitors (ICPI)
L. Spain et al.
ANNALS OF ONCOLOGY (2016)
The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma
Maria Del Castillo et al.
CLINICAL INFECTIOUS DISEASES (2016)
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease
L. Marthey et al.
JOURNAL OF CROHNS & COLITIS (2016)
Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study
Gert Van Assche et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Inhaled corticosteroids: potency, dose equivalence and therapeutic index
Peter T. Daley-Yates
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Ipilimumab-induced colitis in patients with metastatic melanoma
Kara M. De Felice et al.
MELANOMA RESEARCH (2015)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Population-based assessment of adverse events associated with long-term glucocorticoid use
Jeffrey R. Curtis et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4
Kimberly E. Beck et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man
PT Daley-Yates et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
分享论文
